Noninvasive Testing in Women With Suspected Ischemic Heart Disease: Ten Highlights to Guide Quality Clinical Care

• Type of Material: Article
• Authors: Jennifer H. Mieres, Hofstra North Short–LIJ School of Medicine; Leslee J Shaw, Emory University; Nanette K Wenger, Emory University
• Language: English
• Date: 2014-09-01
• Publisher: Wiley Open Access: Various Creative Commons Licenses
• Publication Version: Final Published Version
• Copyright Statement: © 2014 Wiley Periodicals, Inc.
• Final Published Version (URL): http://dx.doi.org/10.1002/clc.22323
• Title of Journal or Parent Work: Clinical Cardiology
• ISSN: 0160-9289
• Volume: 37
• Issue: 9
• Start Page: 515
• End Page: 516
• Keywords: Cardiovascular System & Cardiology; Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

Ischemic heart disease (IHD) has been historically under‐recognized and undertreated in women, with resultant adverse outcomes. The 2014 Consensus Statement from the American Heart Association, which focused on the role of noninvasive testing for women with suspected IHD, provides gender‐specific evidence‐based guidance to the clinician in the use of diagnostic procedures.1 Ten guideposts are presented below, emphasizing determination of risk status and management strategies for symptomatic women.